| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 141.44B | 160.85B | 136.93B | 132.65B | 128.29B | 116.26B |
| Gross Profit | 52.77B | 60.99B | 48.15B | 44.50B | 42.45B | 44.04B |
| EBITDA | 29.23B | 29.68B | 27.45B | 25.92B | 26.45B | 28.84B |
| Net Income | 18.20B | 20.62B | 16.89B | 15.99B | 16.66B | 18.30B |
Balance Sheet | ||||||
| Total Assets | 161.31B | 185.26B | 162.78B | 149.32B | 136.32B | 125.68B |
| Cash, Cash Equivalents and Short-Term Investments | 81.97B | 83.74B | 80.38B | 68.19B | 62.64B | 64.28B |
| Total Debt | 1.67B | 1.69B | 1.81B | 1.93B | 2.06B | 2.20B |
| Total Liabilities | 26.82B | 31.80B | 27.48B | 23.89B | 22.08B | 22.12B |
| Stockholders Equity | 134.49B | 153.46B | 135.30B | 125.43B | 114.24B | 103.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.94B | 18.57B | 11.52B | 4.51B | 12.07B |
| Operating Cash Flow | 0.00 | 18.84B | 24.79B | 15.23B | 8.81B | 18.45B |
| Investing Cash Flow | 0.00 | -13.40B | -29.93B | -9.00B | 230.00M | -9.63B |
| Financing Cash Flow | 0.00 | -6.07B | -5.67B | -5.68B | -5.68B | -5.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥664.11B | 14.02 | 12.11% | 2.68% | 1.73% | 2.18% | |
77 Outperform | ¥23.73T | 40.16 | 19.84% | 0.90% | 11.25% | 16.84% | |
75 Outperform | ¥603.92B | 24.70 | ― | 1.04% | 17.47% | 22.05% | |
73 Outperform | ¥710.87B | 20.92 | 8.48% | 2.02% | 5.20% | 6.54% | |
68 Neutral | ¥8.93B | 135.82 | ― | 0.51% | 19.01% | 64.98% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
40 Underperform | ¥5.66B | -0.47 | ― | ― | -11.65% | -35.29% |